According to a report from Law.com, Pop Vapor Co. LLC, a supplier of disposable e-cigarette products in the United States, has filed a lawsuit on August 2nd in the Northern District Court of Georgia. The company has enlisted the services of Thompson Hine to represent them in this legal action.
The subject of the lawsuit is the Food and Drug Administration (FDA) and the Department of Health and Human Services in the United States. The reason behind it is Pop Vapor's questioning of the FDA's denial of its pre-market tobacco application (PMTA) for its e-cigarette products.
According to a lawsuit, the FDA has rejected the pre-market application for Pop Vapor's disposable e-cigarette product, citing Pop Vapor's failure to provide information on the "length" of the e-cigarette product in the application.
The case, with a docket number of 1:23-cv-03446, involves Pop Vapor Co., LLC as the plaintiff and U.S. Food and Drug Administration, among others, as the defendants.
References:
Pop Vapor Sues FDA, Claiming It Denied E-Cig Application Due to Product’s Length
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
